FAKTOR OPTIONSSCHEIN - NOVO-NORDISK B | Delayed Deutsche Boerse AG 10:21:23 2024-06-26 EDT | ||
| 6.78 EUR | -15.36% |
|
| Current month | +188.13% | ||
| 1 month | +173.38% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
More news
| Date | Price | Change |
|---|---|---|
| 24-06-26 | 6.78 | -15.36% |
| 24-06-25 | 8.01 | +47.24% |
| 24-06-24 | 5.44 | -0.18% |
| 24-06-21 | 5.45 | -0.18% |
| 24-06-20 | 5.46 | +12.11% |
Delayed Quote Deutsche Boerse AG
Last update June 26, 2024 at 10:21 am
More quotesStatic data
| Product type | Productos Exóticos |
|---|---|
| Buy / Sell | CALL |
| Underlying | NOVO NORDISK A/S |
| Issuer | 
BNP Paribas
|
| WKN | PC15N0 |
| ISIN | DE000PC15N07 |
| Date issued | 2022-08-31 |
| Strike | 1,028 kr |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 50 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 263.2 € |
|---|---|
| Lowest since issue | 0.55 € |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
1,028
DKK
Average target price
938.1
DKK
Spread / Average Target
-8.74%
- Stock Market
- Certificates
- Certificat
